#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Comment on Low concentration of plasma cholesterol and type 2. diabetes mellitus


Authors: Ivan Tkáč
Authors‘ workplace: Excelentný tím pre výskum aterosklerózy (EXTASY), IV. interná klinika UPJŠ LF a UN LP, Košice
Published in: AtheroRev 2021; 6(1): 44-45
Category:


Sources
  1. Hubáček JA. Nízká hladina cholesterolu a diabetes 2. typu. AtheroReview 2021; 6(1): 40–43.

  2. Ridker PM, Danielson E, Fonseca FAH et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359(21): 2195–2207. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa0807646>.

  3. Sattar N, Preiss D, Murray HM et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010; 375(9716): 735–742. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(09)61965–6>.

  4. Lotta LA, Sharp SJ, Burgess S et al. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes. A meta-analysis. JAMA 2016; 16(13): 1383–1391. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2016.14568>.

  5. Kohli P, Waters DD, Nemr R et al. Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics. An analysis from TNT and IDEAL. J Am Coll Cardiol 2015; 65(4): 401–404. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2014.10.053>.

  6. Ference BA, Robinson JG, Brook RD et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med 2016; 375(22): 2144–2153. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1604304>.

  7. Sabatine MS, Giugliano RP, Keech AC et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017; 376(18): 1713–1722. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1615664>.

  8. Mach F, Beigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41(1): 111–188. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehz455>.

Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adults

Article was published in

Athero Review

Issue 1

2021 Issue 1

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#